Concepedia

Saioa Mendaza

SM

5

Publications

138

Citations

5

H-Index

2016

Active since

Affiliations

Navarrabiomed(Current)

Complejo Hospitalario de Navarra

Navarre Institute of Health Research

Universidad Publica de Navarra

Institut d'Investigació Biomédica de Bellvitge

Saioa Mendaza is an author at Navarrabiomed specializing in pathology, breast cancer, and gene expression.

Top concepts

Publications per year

2016–2020

5

Publications

5

ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer

Saioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal‐Santesteban et al. · International Journal of Molecular Sciences · 2020 · 54 citations · Full text

<i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer

Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia et al. · Oncotarget · 2017 · 34 citations · Full text

Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix

Saioa Mendaza, Joaquín Fernández‐Irigoyen, Enrique Santamaría et al. · International Journal of Molecular Sciences · 2020 · 21 citations · Full text

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia et al. · Clinical Epigenetics · 2017 · 15 citations · Full text

Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA

Esperanza Martín‐Sánchez, E. Pernaut-Leza, Saioa Mendaza et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2016 · 14 citations

, , +11

Rows per page

1–5 of 5